Venus Concept Financials
VERO Stock | USD 0.32 0.01 3.03% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 3.08 | 2.1324 |
|
|
The essential information of the day-to-day investment outlook for Venus Concept includes many different criteria found on its balance sheet. An individual investor should monitor Venus Concept's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Venus Concept.
Net Income |
|
Venus | Select Account or Indicator |
Understanding current and past Venus Concept Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Venus Concept's financial statements are interrelated, with each one affecting the others. For example, an increase in Venus Concept's assets may result in an increase in income on the income statement.
Venus Concept Stock Summary
Venus Concept competes with Ainos, SurModics, LENSAR, IRIDEX, and CVRx. Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. Venus Concept operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 407 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US92332W1053 |
CUSIP | 92332W105 76133C103 92332W204 |
Location | Ontario; Canada |
Business Address | 235 Yorkland Boulevard, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.venus.ai |
Phone | 877 848 8430 |
Currency | USD - US Dollar |
Venus Concept Key Financial Ratios
Return On Equity | -4.64 | ||||
Profit Margin | (0.72) % | ||||
Operating Margin | (0.34) % | ||||
Price To Sales | 0.03 X | ||||
Revenue | 76.35 M |
Venus Concept Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 191.1M | 160.5M | 153.9M | 125.4M | 93.7M | 102.0M | |
Other Current Liab | 24.5M | 21.4M | 17.3M | 15.9M | 13.5M | 13.4M | |
Net Debt | 53.4M | 45.3M | 47.0M | 72.2M | 74.3M | 78.0M | |
Retained Earnings | (75.7M) | (157.4M) | (180.4M) | (224.1M) | (261.9M) | (275.0M) | |
Accounts Payable | 9.4M | 6.3M | 8.4M | 8.0M | 9.0M | 6.1M | |
Cash | 15.7M | 34.3M | 30.9M | 11.6M | 5.4M | 5.1M | |
Other Assets | 37.0M | 22.7M | 28.8M | 1.0 | 1.15 | 1.09 | |
Long Term Debt | 61.2M | 79.6M | 77.3M | 70.0M | 80.5M | 47.5M | |
Net Receivables | 59.0M | 56.4M | 46.9M | 37.3M | 30.6M | 29.9M | |
Long Term Debt Total | 5.3M | 19.4M | 61.2M | 75.5M | 86.8M | 91.2M | |
Capital Surpluse | 177.8M | 194.8M | 149.8M | 201.6M | 231.8M | 133.8M | |
Inventory | 18.8M | 17.8M | 20.5M | 23.9M | 28.7M | 15.4M | |
Other Current Assets | 3.1M | 7.0M | 12.2M | 11.3M | 1.8M | 1.7M | |
Total Liab | 114.4M | 116.8M | 112.3M | 116.6M | 107.1M | 82.5M | |
Total Current Assets | 99.7M | 115.4M | 107.0M | 84.0M | 66.4M | 70.5M | |
Short Term Debt | 49K | 7.8M | 543K | 11.3M | 5.7M | 5.8M | |
Short Long Term Debt | 49K | 7.8M | 543K | 7.7M | 7.0M | 4.2M | |
Other Liab | 7.7M | 5.0M | 4.6M | 3.7M | 3.4M | 4.2M | |
Net Tangible Assets | 24.6M | 24.4M | 25.4M | 25.6M | 23.0M | 22.4M | |
Net Invested Capital | 143.2M | 123.8M | 118.8M | 85.8M | 98.7M | 95.1M | |
Net Working Capital | 51.5M | 82.9M | 75.8M | 44.4M | 51.1M | 53.6M | |
Common Stock | 24K | 26K | 27K | 29K | 30K | 22.5K | |
Capital Stock | 24K | 26K | 27K | 29K | 33.4K | 24.2K |
Venus Concept Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 7.5M | 8.3M | 5.0M | 4.6M | 6.9M | 5.1M | |
Total Revenue | 110.4M | 78.0M | 105.6M | 99.5M | 76.4M | 66.7M | |
Gross Profit | 76.7M | 51.4M | 74.1M | 66.0M | 52.2M | 42.6M | |
Operating Income | (20.3M) | (40.4M) | (17.5M) | (34.9M) | (28.3M) | (29.7M) | |
Ebit | (20.3M) | (40.4M) | (17.5M) | (39.7M) | (30.2M) | (31.7M) | |
Research Development | 8.0M | 7.8M | 8.3M | 11.0M | 8.2M | 9.0M | |
Ebitda | (18.2M) | (35.6M) | (12.7M) | (35.3M) | (26.1M) | (27.4M) | |
Cost Of Revenue | 33.8M | 26.6M | 31.5M | 33.5M | 24.2M | 24.1M | |
Income Before Tax | (40.4M) | (81.6M) | (22.8M) | (44.3M) | (37.1M) | (39.0M) | |
Net Income | (42.3M) | (82.8M) | (22.1M) | (43.6M) | (37.3M) | (39.1M) | |
Income Tax Expense | 1.9M | 1.2M | (707K) | (722K) | (71K) | (67.5K) | |
Tax Provision | 1.9M | 1.2M | (707K) | (722K) | (711K) | (675.5K) | |
Net Interest Income | (7.8M) | (8.3M) | (5.0M) | (4.6M) | (6.1M) | (6.4M) | |
Minority Interest | 2.5M | (471K) | (872K) | (116K) | (211K) | (200.5K) |
Venus Concept Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | 6.4M | (1.0M) | (4.3M) | (5.8M) | (324K) | (340.2K) | |
Change In Cash | 9.0M | 18.6M | (3.5M) | (19.3M) | (6.2M) | (5.9M) | |
Free Cash Flow | (40.7M) | (28.9M) | (20.3M) | (27.3M) | (13.0M) | (13.6M) | |
Depreciation | 2.0M | 4.8M | 4.9M | 4.5M | 4.1M | 2.8M | |
Other Non Cash Items | 12.5M | 55.4M | 764K | 10.3M | 6.9M | 10.9M | |
Capital Expenditures | 1.1M | 291K | 512K | 336K | 116K | 110.2K | |
Net Income | (42.3M) | (82.8M) | (22.1M) | (43.6M) | (37.1M) | (38.9M) | |
End Period Cash Flow | 15.7M | 34.4M | 30.9M | 11.6M | 5.4M | 5.1M | |
Investments | 6.4M | (2.4M) | (552K) | (336K) | (128K) | (121.6K) | |
Change To Netincome | 14.8M | 11.8M | 56.0M | 3.5M | 4.1M | 3.9M |
Venus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Venus Concept's current stock value. Our valuation model uses many indicators to compare Venus Concept value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Venus Concept competition to find correlations between indicators driving Venus Concept's intrinsic value. More Info.Venus Concept is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Venus Concept's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Venus Concept's earnings, one of the primary drivers of an investment's value.Venus Concept Systematic Risk
Venus Concept's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Venus Concept volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Venus Concept correlated with the market. If Beta is less than 0 Venus Concept generally moves in the opposite direction as compared to the market. If Venus Concept Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Venus Concept is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Venus Concept is generally in the same direction as the market. If Beta > 1 Venus Concept moves generally in the same direction as, but more than the movement of the benchmark.
Venus Concept Thematic Clasifications
Venus Concept is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Medical Equipment | View |
Today, most investors in Venus Concept Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Venus Concept's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Venus Concept growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Venus Concept November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Venus Concept help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Venus Concept. We use our internally-developed statistical techniques to arrive at the intrinsic value of Venus Concept based on widely used predictive technical indicators. In general, we focus on analyzing Venus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Venus Concept's daily price indicators and compare them against related drivers.
Information Ratio | (0.03) | |||
Maximum Drawdown | 94.5 | |||
Value At Risk | (13.79) | |||
Potential Upside | 14.71 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Venus Concept. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Venus Stock, please use our How to Invest in Venus Concept guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Venus Concept. If investors know Venus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Venus Concept listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.97) | Revenue Per Share 11.915 | Quarterly Revenue Growth (0.17) | Return On Assets (0.19) | Return On Equity (4.64) |
The market value of Venus Concept is measured differently than its book value, which is the value of Venus that is recorded on the company's balance sheet. Investors also form their own opinion of Venus Concept's value that differs from its market value or its book value, called intrinsic value, which is Venus Concept's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Venus Concept's market value can be influenced by many factors that don't directly affect Venus Concept's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Venus Concept's value and its price as these two are different measures arrived at by different means. Investors typically determine if Venus Concept is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Venus Concept's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.